Lactobacillus acidophilus supernatant alleviates osteoporosis by upregulating colonic SERT expression

Papers of special note have been highlighted as: • of interest

References

• 1. Laird E, Molloy AM, McNulty H et al. Greater yogurt consumption is associated with increased bone mineral density and physical function in older adults. Osteoporos. Int. 28(8), 2409–2419 (2017).
  Medline CASGoogle Scholar
• 2. Chandra A, Rajawat J. Skeletal aging and osteoporosis: mechanisms and therapeutics. Int. J. Mol. Sci. 22(7), 3553 (2021).
  Medline CASGoogle Scholar
• 3. Sjogren K, Engdahl C, Henning P et al. The gut microbiota regulates bone mass in mice. J. Bone. Miner. Res. 27(6), 1357–1367 (2012).
  MedlineGoogle Scholar
• 4. Li JY, Chassaing B, Tyagi AM et al. Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J. Clin. Invest. 126(6), 2049–2063 (2016).
  MedlineGoogle Scholar
• 5. Collins FL, Rios-Arce ND, Schepper JD et al. The potential of probiotics as a therapy for osteoporosis. Microbiol. Spectr. 5(4), 10.1128/microbiolspec.BAD-0015-2016 (2017).
  Google Scholar
• 6. Maria Remes Troche J, Coss Adame E, Angel Valdovinos Diaz M et al. Lactobacillus acidophilus LB: a useful pharmabiotic for the treatment of digestive disorders. Ther. Adv. Gastroenterol. 13, 1756284820971201 (2020).
  Google Scholar
• 7. Chiang SS, Pan TM. Antiosteoporotic effects of Lactobacillus-fermented soy skim milk on bone mineral density and the microstructure of femoral bone in ovariectomized mice. J. Agric. Food Chem. 59(14), 7734–7742 (2011).
  Medline CASGoogle Scholar
• 8. Ohlsson C, Engdahl C, Fak F et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. PLOS ONE 9(3), e92368 (2014).
  MedlineGoogle Scholar
• 9. Britton RA, Irwin R, Quach D et al. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J. Cell. Physiol. 229(11), 1822–1830 (2014).
  Medline CASGoogle Scholar
• 10. Dar HY, Shukla P, Mishra PK et al. Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balance. Bone Rep. 8, 46–56 (2018). • This study in mice shows that Lactobacillus acidophilus, as a probiotic, has the ability to modulate bone health.
  MedlineGoogle Scholar
• 11. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132(1), 397–414 (2007).
  Medline CASGoogle Scholar
• 12. Xu K, Ma J, Liu Z et al. Effect of sleeve gastrectomy on bone metabolism and serum 5-hydroxytryptamine in obese rats. Medi. Sci. Monitor Int. Med. J. Exp. Clin. Res. 26, e924097 (2020).
  Medline CASGoogle Scholar
• 13. Kumar M, Jiloha RC, Kataria D, Prasad S, Vohora D. Effect of selective serotonin reuptake inhibitors on markers of bone loss. Psychiatry Res. 276, 39–44 (2019).
  Medline CASGoogle Scholar
• 14. Cao YN, Feng LJ, Wang BM et al. Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells. Saudi J. Gastroenterol. 24(1), 59–66 (2018). • In vitro study showing that L. acidophilus and B. longum supernatants can upregulate SERT mRNA and protein levels in intestinal epithelial cells.
  MedlineGoogle Scholar
• 15. Hou CW, Mohanan V, Zachara NE, Grimes CL. Identification and biological consequences of the O-GlcNAc modification of the human innate immune receptor, Nod2. Glycobiology 26(1), 13–18 (2016).
  Medline CASGoogle Scholar
• 16. Watanabe T, Minaga K, Kamata K et al. RICK/RIP2 is a NOD2-independent nodal point of gut inflammation. Int. Immunol. 31(10), 669–683 (2019).
  Medline CASGoogle Scholar
• 17. Layunta E, Latorre E, Forcen R et al. NOD2 modulates serotonin transporter and interacts with TLR2 and TLR4 in intestinal epithelial cells. Cell Physiol. Biochem. 47(3), 1217–1229 (2018). • NOD2 plays a role in intestinal pathophysiology due to its interaction with SERT activity in Caco2 cell line, with RIP2/RICK being the intracellular pathway.
  Medline CASGoogle Scholar
• 18. Tu KN, Lie JD, Wan CKV et al. Osteoporosis: a review of treatment options. P T 43(2), 92–104 (2018).
  MedlineGoogle Scholar
• 19. Sobieszczanska A, Lis M, Suszko-Pawlowska A, Szczypka M. Clomipramine, a tricyclic antidepressant, and selegiline, a monoamine oxidase-B inhibitor, modulate the activity of phagocytic cells after oral administration in mice. J. Pharm. Pharmacol. 72(6), 836–842 (2020).
  Medline CASGoogle Scholar
• 20. Miquelestorena-Standley E, Jourdan ML, Collin C et al. Effect of decalcification protocols on immunohistochemistry and molecular analyses of bone samples. Mod. Pathol. 33(8), 1505–1517 (2020).
  Medline CASGoogle Scholar
• 21. Shang F, Ming L, Zhou Z et al. The effect of licochalcone A on cell-aggregates ECM secretion and osteogenic differentiation during bone formation in metaphyseal defects in ovariectomized rats. Biomaterials 35(9), 2789–2797 (2014).
  Medline CASGoogle Scholar
• 22. You I, Kim EB. Genome-based species-specific primers for rapid identification of six species of Lactobacillus acidophilus group using multiplex PCR. PLOS ONE 15(3), e0230550 (2020).
  Medline CASGoogle Scholar
• 23. Song L, Bi YN, Zhang PY et al. Optimization of the time window of interest in ovariectomized imprinting control region mice for antiosteoporosis research. Biomed. Res. Int. 2017, 8417814 (2017).
  MedlineGoogle Scholar
• 24. Ma S, Qin J, Hao Y, Fu L. Association of gut microbiota composition and function with an aged rat model of senile osteoporosis using 16S rRNA and metagenomic sequencing analysis. Aging (Albany NY). 12(11), 10795–10808 (2020).
  Medline CASGoogle Scholar
• 25. He J, Xu S, Zhang B et al. Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis. Aging (Albany NY). 12(9), 8583–8604 (2020). • Showed decreased bacterial richness and diversity in osteoporosis and significant differences in abundance levels among phyla and genera in the gut microbial community.
  Medline CASGoogle Scholar
• 26. Nilsson AG, Sundh D, Backhed F, Lorentzon M. Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial. J. Intern. Med. 284(3), 307–317 (2018).
  Medline CASGoogle Scholar
• 27. Montazeri-Najafabady N, Ghasemi Y, Dabbaghmanesh MH et al. Supportive role of probiotic strains in protecting rats from ovariectomy-induced cortical bone loss. Probiotics Antimicrob. Proteins 11(4), 1145–1154 (2019).
  Medline CASGoogle Scholar
• 28. Cambeiro-Perez N, Hidalgo-Cantabrana C, Moro-Garcia MA et al. A metabolomics approach reveals immunomodulatory effects of proteinaceous molecules derived from gut bacteria over human peripheral blood mononuclear cells. Front. Microbiol. 9, 2701 (2018).
  MedlineGoogle Scholar
• 29. Guo S, Gillingham T, Guo Y et al. Secretions of Bifidobacterium infantis and Lactobacillus acidophilus protect intestinal epithelial barrier function. J. Pediatr. Gastroenterol. Nutr. 64(3), 404–412 (2017).
  Medline CASGoogle Scholar
• 30. Modder UI, Achenbach SJ, Amin S, Riggs BL, Melton LJ 3rd, Khosla S. Relation of serum serotonin levels to bone density and structural parameters in women. J. Bone Miner. Res. 25(2), 415–422 (2010).
  Medline CASGoogle Scholar
• 31. Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 5(11), 898–907 (2017).
  MedlineGoogle Scholar
• 32. Zhao JG, Zeng XT, Wang J, Liu L. Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: a systematic review and meta-analysis. JAMA 318(24), 2466–2482 (2017).
  Medline CASGoogle Scholar
• 33. Ding K, Hua F, Ding W. Gut microbiome and osteoporosis. Aging Dis. 11(2), 438–447 (2020). • Review systematicly showing that 5-HT signaling transduction system including SERT plays important role in bone development and maintenance.
  MedlineGoogle Scholar
• 34. Santacroce L, Charitos IA, Bottalico L. A successful history: probiotics and their potential as antimicrobials. Expert Rev. Anti. Infect. Ther. 17(8), 635–645 (2019).
  Medline CASGoogle Scholar
• 35. Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J. Clin. Gastroenterol. 47(5), 437–439 (2013).
  MedlineGoogle Scholar
• 36. Land MH, Rouster-Stevens K, Cannon ML et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115(1), 178–181 (2005).
  MedlineGoogle Scholar
• 37. Deng Y, McDonald OG, Means AL et al. Exposure to p40 in early life prevents intestinal inflammation in adulthood through inducing a long-lasting epigenetic imprint on TGFbeta. Cell. Mol. Gastroenterol. Hepatol. 11(5), 1327–1345 (2021).
  MedlineGoogle Scholar
• 38. Salminen S, Collado MC, Endo A et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat. Rev. Gastroenterol. Hepatol. 18(9), 649–667 (2021).
  MedlineGoogle Scholar
• 39. Montazeri-Najafabady N, Ghasemi Y, Dabbaghmanesh MH et al. Exploring the bone sparing effects of postbiotics in the post-menopausal rat model. BMC Complement. Med. Ther. 21(1), 155 (2021). • Showed that postbiotics could ameliorate bone loss resulting from estrogen deficiency and protect against bone loss.
  Medline CASGoogle Scholar
• 40. Yan F, Cao H, Cover TL et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132(2), 562–575 (2007).
  Medline CASGoogle Scholar
• 41. Shen X, Liu L, Peek RM et al. Supplementation of p40, a Lactobacillus rhamnosus GG-derived protein, in early life promotes epidermal growth factor receptor-dependent intestinal development and long-term health outcomes. Mucosal. Immunol. 11(5), 1316–1328 (2018).
  Medline CASGoogle Scholar
• 42. Ommori R, Ouji N, Mizuno F et al. Selective induction of antimicrobial peptides from keratinocytes by staphylococcal bacteria. Microb. Pathog. 56, 35–39 (2013).
  Medline CASGoogle Scholar
• 43. Claes AK, Zhou JY, Philpott DJ. NOD-like receptors: guardians of intestinal mucosal barriers. Physiology (Bethesda) 30(3), 241–250 (2015).
  Medline CASGoogle Scholar
• 44. Pusceddu MM, Barboza M, Keogh CE et al. Nod-like receptors are critical for gut–brain axis signalling in mice. J. Physiol. 597(24), 5777–5797 (2019).
  Medline CASGoogle Scholar